Search

everythinglearnresearchcommunity

for

Search:↓

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Platelet Rich Plasma (PRP) treatment effectively reduces hair fall and increases hair growth in patients with Androgenetic Alopecia (AGA), but it may cause pain.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Current treatments for alopecia show no significant long-term benefits.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Hair follicles are valuable for regenerative medicine and wound healing.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Many skin patients also have mental health issues, and doctors should treat both together.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.